Investor Login

This area is for use by Limited Partners of the funds managed by MML Capital Partners only.

MML Capital Partners uses PEARonline, a secure, web-based service for investor reporting. PEARonline allows investors to access reports, accounts and other fund information 24 hours a day, 365 days a year and additionally gives investors access to all other funds that report through the service from a single site with a single username and password.

To log in to PEARonline, please follow this link. If you would like to gain access to information on our funds through PEARonline, please contact Alison Jackson at ajackson@mmlcapital.com

If you have any questions about PEARonline or need any support using this service, please contact PEARonline on +1 408 740-5226 or email support@pearonline.com

See how we have grown

Press Releases

Sep 2016
IQARUS continues its expansion with RSOH acquisition

MML backed IQARUS (www.iqarus.com) has made its third acquisition in seven months acquiring RS Occupational Health (‘RSOH’), a UK occupational healthcare provider to a diverse range of industries including oil and gas, construction, engineering, manufacturing and public sectors.

RSOH is a leading player in the North Sea market and is a direct competitor to IQARUS’s UK operations, offering medical assessments, sickness absence reviews, travel health and health surveillance.

Tim Mitchell, CEO of IQARUS, said that the acquisition would strengthen IQARUS’ position in the UK market and provide enhanced service delivery to an increasingly diversified customer portfolio.

Robert Devonshire, Investment Director at MML, comments: “RSOH significantly bolsters IQARUS’s UK operations and continues its strong momentum in executing strategic acquisitions within a fragmented market.”

MML invested into IQARUS in October 2015 from it’s recently raised €438m Fund VI.

IQARUS was acquired as a platform from which to develop an international provider of remote healthcare solutions. RSOH is the third acquisition that MML has supported this year alongside significant investment in technology enabled medical solutions.

Case Study

FrontierMEDEX

undefined

By using the mmlcapital.com website you agree to our use of cookies as described in our cookie policy.

Learn More